Deciphering the Dollars: Advanced Medicare Cost Reporting and Appeals Strategies for 2026

Jennifer Eilemberg, Managing Director, Stout, and Janice Suchyta, Partner, Buchalter, discuss areas of legal exposure involving artificial intelligence (AI) in health care, focusing on compliance takeaways and governance strategies for health care organizations. They frame their discussion around three gaps (consent, accountability, and transparency) and dive into the legal and ethical risks AI poses for physicians. Jennifer and Janice spoke about this topic at AHLA’s 2026 Annual Meeting in N...

Insurance coverage for government investigations and regulatory claims is a critical issue for health care organizations right now. Lilit Asadourian, Partner and Insurance Recovery and Counseling Group Co-Chair, Barnes & Thornburg, and Rebecca Cady, U.S. Health Care Practice Group Co-Leader, Lockton, discuss how health care organizations can navigate insurance coverage related to government enforcement activity. They explore the current landscape of government investigations, the types of...

Strategic partnerships are common in the health care industry for good reasons. However, it is also common for these partnerships to run their course or hit roadblocks that may result in a separation. Annapoorani Bhat, Principal, PYA, and Jeanna P. Gunville, Partner, Morgan Lewis, use case studies to discuss some best practices for legal and valuation professionals supporting their health care clients through the evaluation and possible separation of strategic partnerships. Annapoorani and Je...

A fair market value opinion and a carefully constructed agreement are foundational for physician compensation compliance, but they’re only part of the equation. Major enforcement actions often hinge on what happens after the agreement is signed. Eric Leafgreen, Vice President of Physician Compensation & Strategic Services, Ludi, and Alex Krouse, Associate General Counsel, Parkview Health, discuss the real-world breakdowns that lead to compliance failures in this space. They explore the es...

Rob Gerberry, Adjunct Faculty, University of Notre Dame, speaks with Michael Peregrine, Fellow, SullivanCotter, about the latest judicial ruling on a longstanding staple of health care corporate governance—the board’s oversight obligations with respect to corporate compliance. They discuss the Delaware Court of Chancery’s recent decision, at the pleading stage, to dismiss Caremark claims against the officers and directors of the aircraft manufacturer Boeing, and they delve into key takeaways ...